glp 1 and alzheimers GLP-1 drugs show promise in Alzheimer's treatment despite trial setback | Zain Khalpey, MD, PhD, FACS posted on the topic Role of glucagon-like peptide-1 receptor

investigated the regulatory effect of epithalon on the production of melatonin and cortisol in senescent monkeys, finding that the peptide significantly stimulated melatonin synthesis, thus normalizing the circadian rhythm of cortisol secretion [11]

Experimental research has explored its interactions with cytokine activity, inflammatory mediators, gastrointestinal tissues, and cellular communication networks associated with immune responses

& Polyak, K

Chores like cleaning, and his very physical delivery job, feel much easier

Theres another big caveat, too: theres a lot of people who end up quitting these drugs after about two years

Ipamorelin was not among the peptides the committee reconsidered at its July 2026 meeting, so as of August 2026 that 2024 recommendation still stands